Inventor · disambiguated record
Mario Perro
Also filed as: PERRO MARIO
4 granted patents·4 pending applications·19 citations·filing 2016–2023
72Inventor score
Top patents by PatentIndex Score
8 records- 0196US11718680B2Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonistsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 8, 2023·5 cites·32 claims
- 0290US10287352B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2016·Granted May 14, 2019·10 cites·21 claims
- 0389US11130810B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·4 cites·36 claims
- 0471US2024109976A1Combination therapy of anti-cd20/anti-cd3 bispecific antibodies and 4-1bb (cd137) agonistsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0570US12391757B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2021·Granted Aug 19, 2025·0 cites·20 claims
- 0662US2024002546A1Combination therapy employing a pd1-lag3 bispecific antibody and a cd20 t cell bispecific antibodyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0757US2024228650A9CD3/BCMA/CD38 Trispecific AntibodiesIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 0856US2024092856A1Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →